# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA4421085 | B | Inhibition of N-terminal 6x-His-tagged recombinant human SOS1 catalytic domain (residues 564 to 1049 residues) expressed in Escherichia coli BL21 (DE3) assessed as reduction in 50 nM SOS1-mediated GDP/GTP nucleotide exchange upon 2 uM N-terminal-GST-tagged H-Ras (1 to 166 residues) by BODIPY-FL-GDP dissociation assay | Homo sapiens | 36 | assay format | Patent Bioactivity Data | ||
2. | ALA4421087 | B | Binding affinity to N-terminal 6x-His-tagged recombinant human SOS1 catalytic domain (residues 564 to 1049 residues) expressed in Escherichia coli BL21 (DE3) by label-free microscale thermophoresis analysis | Homo sapiens | 4 | assay format | Patent Bioactivity Data | ||
3. | ALA4421088 | B | Binding affinity to N-terminal 6x-His-tagged recombinant human SOS1 catalytic domain (residues 564 to 1049 residues) expressed in Escherichia coli BL21 (DE3) assessed as reduction in N-terminal-GST-tagged H-Ras (1 to 166 residues) binding to NT-647 cysteine-labeled purified SOS1 catalytic domain by competitive microscale thermophoresis analysis | Homo sapiens | 4 | assay format | Patent Bioactivity Data | ||
4. | ALA4421101 | B | Inhibition of SOS1 in human DU145 cells assessed as reduction in cell proliferation at 20 to 60 uM incubated for 3 days and measured every 24 hrs by MTS assay | Homo sapiens | 2 | cell-based format | Patent Bioactivity Data | ||
5. | ALA4421123 | B | Inhibition of N-terminal 6x-His-tagged recombinant human SOS1 catalytic domain (residues 564 to 1049 residues) expressed in Escherichia coli BL21 (DE3) assessed as reduction in 50 nM SOS1-mediated GTP loading of 2 uM N-terminal-GST-tagged H-Ras (1 to 166 residues) by BODIPY-TR-GTP GTP loading exchange assay | Homo sapiens | 2 | assay format | Patent Bioactivity Data | ||
6. | ALA4421124 | B | Binding affinity to NT-647 cysteine-labeled and N-terminal-GST-tagged recombinant human H-Ras (1 to 166 residues) expressed in Escherichia coli BL21 (DE3) at up to 100 uM by microscale thermophoresis analysis | Homo sapiens | 3 | assay format | Patent Bioactivity Data | ||
7. | ALA4421125 | B | Inhibition of SOS1 in overnight serum-starved mouse NIH/3T3 cells assessed as effect on Ras-GTP levels at 20 to 40 uM pre-incubated for 16 hrs before EGF stimulation for 5 mins by GST-Raf1 effector domain pulldown assay | Mus musculus | 1 | assay format | Patent Bioactivity Data | ||
8. | ALA4421126 | B | Inhibition of SOS1 in overnight serum-starved mouse NIH/3T3 cells assessed as reduction in ERK1/2 phosphorylation at 20 to 40 uM pre-incubated for 16 hrs before EGF stimulation for 5 mins by Western blot analysis | Mus musculus | 1 | assay format | Patent Bioactivity Data | ||
9. | ALA4421127 | B | Inhibition of SOS1 in overnight serum-starved mouse NIH/3T3 cells assessed as reduction in Akt phosphorylation at 20 to 40 uM pre-incubated for 16 hrs before EGF stimulation for 5 mins by Western blot analysis | Mus musculus | 1 | assay format | Patent Bioactivity Data | ||
10. | ALA4421132 | B | Inhibition of SOS1 in overnight serum-starved human DU145 cells assessed as reduction in ERK1 phosphorylation at 20 to 40 uM pre-incubated for 16 hrs before EGF stimulation for 5 mins by Western blot analysis | Homo sapiens | 2 | assay format | Patent Bioactivity Data | ||
11. | ALA4421133 | B | Inhibition of N-terminal 6x-His-tagged recombinant human SOS1 catalytic domain (residues 564 to 1049 residues) expressed in Escherichia coli BL21 (DE3) assessed as reduction in 50 nM SOS1-mediated GDP/GTP nucleotide exchange upon 2 uM N-terminal-GST-tagged H-Ras (1 to 166 residues) at 10 uM by BODIPY-FL-GDP dissociation assay | Homo sapiens | 1 | assay format | Patent Bioactivity Data | ||
12. | ALA4421136 | B | Inhibition of N-terminal 6x-His-tagged recombinant human ITSN1 DH and PH domain (1227 to 1571 residues) expressed in Escherichia coli BL21 (DE3) assessed as reduction in 50 nM SOS1-mediated GDP/GTP nucleotide exchange upon 2 uM N-terminal-GST-tagged Cdc42 (1 to 182 residues) at 10 uM by BODIPY-FL-GDP dissociation assay | Homo sapiens | 1 | assay format | Patent Bioactivity Data | ||
13. | ALA4421138 | B | Inhibition of SOS1 in overnight serum-starved mouse NIH/3T3 cells assessed as reduction in cell proliferation at 20 to 60 uM incubated for 3 days and measured every 24 hrs by MTS assay | Mus musculus | 1 | assay format | Patent Bioactivity Data |